Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway

Publication date: September 2021Source: Biomedicine & Pharmacotherapy, Volume 141Author(s): Jiamei Zhang, Huihui Sun, KunXiu Jiang, Xingzhuo Song, Xirui Wang, Yuqian Yang, Hanying Liu, Qingxuan Ji, Xue Yu, Yonggang Liu, Jing Han, Wei Wang
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research